Overview


According to FutureWise analysis, the market for autism spectrum disorder in 2023 is US$ 30 billion, and is expected to reach US$ 43.71 billion by 2031 at a CAGR of 4.80%.

Autism spectrum disorder is a neurological condition that affects how people perceive and relate to one another, which can cause problems with social interaction and communication. Another characteristic of the condition is its limited and recurrent behavioural patterns. The term "spectrum" in autism spectrum disorder alludes to the wide range of signs and severity. Previously assumed to be separate disorders, autism spectrum disorder now includes Asperger's syndrome, childhood disintegrative disorder, and an undiscovered type of pervasive developmental disability.

Early-onset autism spectrum disease eventually results in issues with social, academic, and occupational functioning in society. Within the first year, autism signs in youngsters are frequently visible. A tiny percentage of kids seem to develop normally in the first year, but between the ages of 18 and 24 months, when they start to show symptoms of autism, they undergo a period of regression. Some infants display early autism spectrum disorder symptoms, such as limited eye contact, a lack of responsiveness to their names, or a lack of interest in their careers. Other kids might grow normally during the start of few months or years of life but then all of a sudden turn introverted, hostile, or lose their gained language abilities. Typically, signs appear by the age of two. Since autism spectrum disorders range in severity from low functioning to high functioning, each autistic child will likely exhibit a distinct behavioural pattern. Even though there is no known treatment for autism spectrum condition, intense, early intervention can significantly improve many kids' lives.

FutureWise Market Research has published a report that provides an insightful analysis of autism spectrum disorder market trends that are affecting the overall market growth. This report will provide a detailed analysis of market share, regional insights, and competitor analysis that includes stature of key manufacturers operational in this industry. According to the analysis conducted by FutureWise research analysts, the autism spectrum disorder market is estimated to register a considerable growth rate over the forecast period. This report lists the market segments and potential prospects available across this industry, in addition providing crucial information on the total valuation currently held by the industry. Moreover, this report will assist key management individuals in an organisation to enhance their decisions pertaining to business expansion as well as strategic changes for increasing customer base.

  • Abbvie Inc
  • Axial Therapeutics
  • Bristol Myers Squibb Co.
  • Cognoa Inc
  • Curemark LLC
  • dfusion inc
  • Jonson And Johnson
  • Jazz Pharmaceuticals
  • Novartis AG

(Note: The list of the major players will be updated with the latest market scenario and trends)

Recent developments by key players in Autism Spectrum Disorder Market:

In March 2022- STALICLA, a Swiss clinical-stage biotech business in charge of omics-based therapeutic development for people with neurodevelopmental disorders (NDDs), announced that the phase 1b trials for its primary drug candidate, STP1, were completed with great success. These clinical findings pave the path for STALICLA's precision medicine discovery platform to be used for the first time to treat autism spectrum disorders.

The prevalence of autism spectrum disorder is rising globally, individuals are becoming more aware of the condition and accessible treatments, and more investments are being made in autism spectrum disorder, contributing to the market's expansion. For instance, according to a World Health Organisation (WHO), update from March 2022, one in 100 children has autism. Expanding efforts in research and development for effective therapies, rising government financing and investment, and expanding organizing initiatives to increase public awareness are driving the growth of the ASD market. The market will continue to grow throughout the forecast period as a result of technological advancements that enhance patient care and modernize the medical sector. Moreover, large-scale research studies conducted by organizations to evaluate the effectiveness and safety of drugs in ASD patients are predicted to be among the primary factors in the market for ASD. These investigations' great results provide the market with brand-new opportunities for growth. For instance, in March 2022, Stalicla completed phase 1b trials of precision medicine candidate STP1, and the results showed symptom decrease in ASD patients. As a result, it is expected that the market will be driven by the trial's successful conclusion and any subsequent product approvals. However, Despite the rising need for effective clinical trials and ASD treatments, no medicine has yet been approved for this condition. Knowledge gaps and complex clinical research models are a few major obstacles to research and drug development. The market growth for autistic spectrum disorders is further constrained by a shortage of specialists who are equipped to assess ASDs. The length of time and effectiveness required for patient care and treatment are additional factors contributing to market barriers.

By Drug Type

  • Austin Disorder
  • Asperger Syndrome
  • Pervasive development disorder
  • Others

By Drug Class

  • Behavioural Approaches
    • Gender
      • Male
      • Female
  • Early Intervention
    • Gender
      • Male
      • Female
  • Medication
    • Gender
      • Male
      • Female
  • Other Services
    • Gender
      • Male
      • Female

By Distribution Channel

  • Hospitals
  • Education Counsellor Center
  • Others

By Region

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East and Africa

This market research report also emphasis on factors affecting the growth rate in various regions listed above. A deep-down analysis of region will also be provided in the final version of this market which is based on conclusion of primary interviews and secondary data point gathered during the process.

By region, the market is segmented into North America, Latin America, Europe, Asia-Pacific, and Middle East & Africa. North America registered the highest share in the market in 2022. The prevalence of autism spectrum diseases, rising research and development, and increased spending are the main drivers of market expansion in the region. For instance, according to a March 2022 update from the Centres for Disease Control and Prevention (CDC), ASD has been diagnosed in around 1 in 44 children. As a result, there is a rising need for treatment of autism spectrum conditions in the area. The market is expanding due to the increasing number of initiatives being made by market participants. For instance, XRHealth, the portal to the healthcare metaverse, announced in April 2022 that their virtual/augmented reality therapy is now offered in the United States to treat people with autism. Such advancements are predicted to stimulate drug development and boost market expansion.

  • Tier 1 players- established companies in the market with a major market share
  • Tier 2 players
  • Emerging players which are growing rapidly
  • New Entrants

  • Growth prospects
  • SWOT analysis
  • Key trends
  • Key data-points affecting market growth

  • To provide with an exhaustive analysis on the Autism Spectrum Disorders Market By Drug Type, By Drug Class, By Distribution Channel and By Region.
  • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
  • To evaluate and forecast micro-markets and the overall market
  • To predict the market size, in key regions— North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
  • To record and evaluate competitive landscape mapping- product launches, technological advancements, mergers and expansions

  • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
  • The customization Mobility Care offered are free of charge with purchase of any license of the report
  • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

Table of Contents


  • 1.   Market Introduction
    •   1. Objectives of the Study
        2. Market Definition
        3. Market Scope
         3.1. Years Considered for the Study
         3.2. Market Covered
        4. Currency
        5. Limitations
        6. Stakeholders
  • 2.   Research Methodology
    •   1. Research Data
         1.1. Secondary Data
          1.1.1. Key Data from Secondary Sources
         1.2. Primary Data
          1.2.1. Key Data from Primary Sources
        2. Market Size Estimation
        3. Market Breakdown and Data Triangulation
        4. Assumptions for the Study
  • 3.   Executive Summary
    •   1. Market Outlook
        2. Segment Outlook
        3. Competitive Insights
  • 4.   Autism Spectrum Disorders Market Variables, Trends and Scope
    •   1. Market Lineage Outlook
        2. Penetration and Growth Prospect Mapping
        3. Industry Value Chain Analysis
        4. Cost Analysis Breakdown
        5. Technology Overview
        6. Regulatory Framework
         6.1. Reimbursement Framework
         6.2. Standards and Compliances

  • 5.   Market Overview
    •   1. Market Dynamics
         1.1. Market Driver Analysis
          1.1.1. Increasing focus of Autism Spectrum Disorders Market Companies on Brand Protection
          1.1.2. Untapped Opportunities in Emerging Regions
         1.2. Market Restraint Analysis
          1.2.1. High Cost Associated with Implementation of Predictive Analysis
         1.3. Industry Challenges
          1.3.1. Presence of Ambiguous Regulatory Framework
  • 6.   Autism Spectrum Disorders Market Analysis Tools
    •   1. Industry Analysis - Porter’s
         1.1. Supplier Power
         1.2. Buyer Power
         1.3. Substitution Threat
         1.4. Threat from New Entrants
         1.5. Competitive Rivalry
        2. Pestel Analysis
         2.1. Political Landscape
         2.2. Environmental Landscape
         2.3. Social Landscape
         2.4. Technology Landscape
         2.5. Legal Landscape
        3. Major Deals And Strategic Alliances Analysis
         3.1. Joint Ventures
         3.2. Mergers and Acquisitions
         3.3. Licensing and Partnership
         3.4. Technology Collaborations
         3.5. Strategic Divestments
        4. Market Entry Strategies
        5. Case Studies
  • 7.   Autism Spectrum Disorders Market, By Drug Type Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Austin Disorder
        2. Asperger Syndrome
        3. Pervasive development disorder
        4. Others

  • 8.   Autism Spectrum Disorders Market, By Drug Class Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Behavioural Approaches
         1.1. Gender
             1.1.1. Male
             1.1.2. Female
        2. Early Intervention
         2.1. Gender
            2.1.1 Male
            2.1.2 Female
        3. Medication
         3.1. Gender
            3.1.1 Male
            3.1.2 Female
        4. Other Services
         4.1. Gender
            4.1.1 Male
            4.1.2 Female

  • 9.   Autism Spectrum Disorders Market, By Distribution Channel Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Hospitals
        2. Education Counsellor Center
        3. Others

  • 10.   North America Autism Spectrum Disorders Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. U.S.A
         2.2. Canada
         2.3. Mexico
        3. Market Size (USD Million) Forecast for North America 2023-2031

  • 11.   Latin America Autism Spectrum Disorders Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Brazil
         2.2. Venezuela
         2.3. Argentina
         2.4. Rest of Latin America
        3. Market Size (USD Million) Forecast for Latin America 2023-2031

  • 12.   Europe Autism Spectrum Disorders Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Germany
         2.2. U.K
         2.3. France
         2.4. Italy
         2.5. Spain
         2.6. Russia
         2.7. Poland
         2.8. Rest of Europe
        3. Market Size (USD Million) Forecast for Europe 2023-2031

  • 13.   Asia Pacific Autism Spectrum Disorders Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Japan
         2.2. China
         2.3. India
         2.4. Australia and New Zealand
         2.5. ASEAN
         2.6. Rest of Asia Pacific
        3. Market Size (USD Million) Forecast for Asia Pacific 2023-2031

  • 14.   Middle East and Africa Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. GCC
         2.2. Israel
         2.3. South Africa
         2.4. Rest of MEA
        3. Market Size (USD Million) Forecast for MEA 2023-2031

  • 15.   Market Share Analysis and Competitive Landscape
    •   1. Global Landscape - Key Players, Revenue and Presence
        2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3)
        3. Global Emerging Companies
        4. North America - Market Share Analysis and Key Regional Players
        5. Europe - Market Share Analysis and Key Regional Players
        6. Asia Pacific - Market Share Analysis and Key Regional Players
        7. Global Key Player - Growth Matrix
  • 16.   Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts)
    •   1. Abbvie Inc
         1.1. Company Overview
         1.2. Product Portfolio
         1.3. SWOT Analysis
         1.4. Financial Overview
         1.5. Strategic Overview
        2. Axial Therapeutics
         2.1. Company Overview
         2.2. Product Portfolio
         2.3. SWOT Analysis
         2.4. Financial Overview
         2.5. Strategic Overview
        3. Bristol Myers Squibb Co.
         3.1. Company Overview
         3.2. Product Portfolio
         3.3. SWOT Analysis
         3.4. Financial Overview
         3.5. Strategic Overview
        4. Cognoa Inc
         4.1. Company Overview
         4.2. Product Portfolio
         4.3. SWOT Analysis
         4.4. Financial Overview
         4.5. Strategic Overview
        5. Curemark LLC
         5.1. Company Overview
         5.2. Product Portfolio
         5.3. SWOT Analysis
         5.4. Financial Overview
         5.5. Strategic Overview
        6. dfusion inc
         6.1. Company Overview
         6.2. Product Portfolio
         6.3. SWOT Analysis
         6.4. Financial Overview
         6.5. Strategic Overview
        7. Jonson And Johnson
         7.1. Company Overview
         7.2. Product Portfolio
         7.3. SWOT Analysis
         7.4. Financial Overview
         7.5. Strategic Overview
        8. Jazz Pharmaceuticals
         8.1. Company Overview
         8.2. Product Portfolio
         8.3. SWOT Analysis
         8.4. Financial Overview
         8.5. Strategic Overview
        9. Novartis AG
         9.1. Company Overview
         9.2. Product Portfolio
         9.3. SWOT Analysis
         9.4. Financial Overview
         9.5. Strategic Overview

  • 17.   Pre and Post COVID-19 Impact
    •   1. Positive influence on the healthcare industry
        2. The financial disruption of the manufacturing sector
        3. Impact of COVID-19 on emerging companies
        4. Significant mandates in the regulations initiated by healthcare administrations
        5. The overall economic slowdown of the developing and developed nations
  • 18.   FutureWise SME Key Takeaway Points for Client

Related Market

Autism Spectrum Disorder Therapeutics Market

Read More

Autism Spectrum Disorder Management Market

Read More
Partner

Our Clients